Publications by authors named "Meaghan Wall"

49Publications

Failure of tofacitinib to achieve an objective response in a T-lymphoblastic leukemia with activating mutations.

Cold Spring Harb Mol Case Stud 2020 Aug 25;6(4). Epub 2020 Aug 25.

Department of Hematology, Monash Health, Clayton, 3168, Victoria, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1101/mcs.a004994DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7476415PMC
August 2020

Modeling human RNA spliceosome mutations in the mouse: not all mice were created equal.

Exp Hematol 2019 02 6;70:10-23. Epub 2018 Nov 6.

St. Vincent's Institute, Fitzroy, Victoria 3065, Australia; Department of Medicine, St. Vincent's Hospital, University of Melbourne, Fitzroy, Victoria 3065, Australia; Mary MacKillop Institute for Health Research, Australian Catholic University, Melbourne, Victoria 3000, Australia. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S0301472X183087
Publisher Site
http://dx.doi.org/10.1016/j.exphem.2018.11.001DOI Listing
February 2019

What does good FISHing look like in MDS?

Leuk Lymphoma 2019 03 8;60(3):571-572. Epub 2018 Nov 8.

d Department of Pathology , Peter MacCallum Cancer Centre , Melbourne , Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428194.2018.1529312DOI Listing
March 2019

Clinicopathological features and outcomes of progression of CLL on the BCL2 inhibitor venetoclax.

Blood 2017 06 4;129(25):3362-3370. Epub 2017 May 4.

Department of Clinical Haematology and Bone Marrow Transplantation, The Royal Melbourne Hospital, Parkville, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2017-01-763003DOI Listing
June 2017

The Dicentric Chromosome dic(20;22) Is a Recurrent Abnormality in Myelodysplastic Syndromes and Is a Product of Telomere Fusion.

Cytogenet Genome Res 2016 4;150(3-4):262-272. Epub 2017 Mar 4.

Victorian Cancer Cytogenetics Service, St Vincent's Hospital, University of Melbourne, Melbourne, VIC, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000456677DOI Listing
April 2017

Recurrent Cytogenetic Abnormalities in Myelodysplastic Syndromes.

Authors:
Meaghan Wall

Methods Mol Biol 2017 ;1541:209-222

Victorian Cancer Cytogenetics Service, St. Vincent's Hospital, 41 Victoria Parade, Fitzroy, Melbourne, VIC, 3065, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/978-1-4939-6703-2_18DOI Listing
January 2018

Adenosine-to-inosine RNA editing by ADAR1 is essential for normal murine erythropoiesis.

Exp Hematol 2016 10 1;44(10):947-63. Epub 2016 Jul 1.

St. Vincent's Institute of Medical Research, Fitzroy, Victoria, Australia; Department of Medicine, St. Vincent's Hospital, University of Melbourne, Fitzroy, Victoria, Australia. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.exphem.2016.06.250DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5035604PMC
October 2016

Current challenges and novel treatment strategies in double hit lymphomas.

Ther Adv Hematol 2016 Feb;7(1):52-64

Department of Clinical Hematology and Bone Marrow Transplant, Royal Melbourne Hospital, Parkville, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/2040620715608091DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4713886PMC
February 2016

The Transcription Factor ASCIZ and Its Target DYNLL1 Are Essential for the Development and Expansion of MYC-Driven B Cell Lymphoma.

Cell Rep 2016 Feb 28;14(6):1488-1499. Epub 2016 Jan 28.

St. Vincent's Institute of Medical Research, Fitzroy, VIC 3065, Australia; Department of Medicine, St. Vincent's Hospital, The University of Melbourne, Fitzroy, VIC 3065, Australia. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.celrep.2016.01.012DOI Listing
February 2016

Monosomal karyotype predicts inferior survival independently of a complex karyotype in patients with myelodysplastic syndromes.

Cancer 2015 Sep 4;121(17):2892-9. Epub 2015 Jun 4.

Victorian Cancer Cytogenetics Service, St Vincent's Hospital, Melbourne, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.29396DOI Listing
September 2015

The molecular pathogenesis of B-cell non-Hodgkin lymphoma.

Eur J Haematol 2015 Oct 9;95(4):280-93. Epub 2015 Jun 9.

Peter MacCallum Cancer Centre, Melbourne, Vic., Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/ejh.12589DOI Listing
October 2015

A rare case of IGH/MYC and IGH/BCL2 double hit primary plasma cell leukemia.

Haematologica 2015 Feb 7;100(2):e60-2. Epub 2014 Nov 7.

Alfred Hospital, Myeloma Research Group, Australian Centre for Blood Diseases, Monash University, Melbourne

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3324/haematol.2014.111385DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4803129PMC
February 2015

Src family kinases and their role in hematological malignancies.

Leuk Lymphoma 2015 Mar 21;56(3):577-86. Epub 2015 Jan 21.

Haematology Department and Victorian Cancer Cytogenetics Service, St Vincent's Hospital , Fitzroy , Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/10428194.2014.907897DOI Listing
March 2015

Underestimation of myelodysplastic syndrome incidence by cancer registries: Results from a population-based data linkage study.

Cancer 2014 Jun 18;120(11):1686-94. Epub 2014 Mar 18.

Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, Australia; Research and Development, Australian Red Cross Blood Service, Melbourne, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.28641DOI Listing
June 2014

A dimorphic blast population demonstrates Philadelphia-positive mixed phenotype acute leukaemia.

Pathology 2014 Apr;46(3):244-6

1Laboratory Haematology Department, The Alfred Hospital, Melbourne 2Victorian Cancer Cytogenetics Service, St Vincent's Hospital Melbourne, Fitzroy, Vic, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PAT.0000000000000086DOI Listing
April 2014

Genome organization and the role of centromeres in evolution of the erythroleukaemia cell line HEL.

Evol Med Public Health 2013 Jan 1;2013(1):225-40. Epub 2013 Oct 1.

Victorian Cancer Cytogenetics Service, St Vincent's Hospital, Melbourne, Fitzroy, Vic, Australia; Department of Medicine, St Vincent's Hospital, University of Melbourne, Melbourne, Vic, Australia; and PathWest Department of Diagnostic Genomics, QEII Medical Centre, Nedlands, WA, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/emph/eot020DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3868402PMC
January 2013

Synergistic inhibition of ovarian cancer cell growth by combining selective PI3K/mTOR and RAS/ERK pathway inhibitors.

Eur J Cancer 2013 Dec 3;49(18):3936-44. Epub 2013 Sep 3.

Oncogenic Signalling and Growth Control Program, Peter MacCallum Cancer Centre, Locked Bag 1, A'Beckett St, Melbourne, Victoria 8006, Australia; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria 3010, Australia; Department of Biochemistry and Molecular Biology, University of Melbourne, Parkville, Victoria 3010, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2013.08.007DOI Listing
December 2013

Resistance to CDK2 inhibitors is associated with selection of polyploid cells in CCNE1-amplified ovarian cancer.

Clin Cancer Res 2013 Nov 4;19(21):5960-71. Epub 2013 Sep 4.

Authors' Affiliations: Peter MacCallum Cancer Centre, East Melbourne; Victorian Cancer Cytogenetics Service, St Vincent's Hospital, Melbourne; Sir Peter MacCallum Department of Oncology; Departments of Pathology, Biochemistry and Molecular Biology, and Medicine; Centre for Translational Pathology, University of Melbourne, Parkville, Victoria, Australia; Dana-Farber Cancer Institute, Boston; and The Broad Institute of Harvard and MIT, Cambridge, Massachusetts.

View Article

Download full-text PDF

Source
http://clincancerres.aacrjournals.org/content/early/2013/08/
Web Search
http://clincancerres.aacrjournals.org/content/19/21/5960.ful
Web Search
http://clincancerres.aacrjournals.org/cgi/doi/10.1158/1078-0
Publisher Site
http://dx.doi.org/10.1158/1078-0432.CCR-13-1337DOI Listing
November 2013

CGH and SNP array using DNA extracted from fixed cytogenetic preparations and long-term refrigerated bone marrow specimens.

Mol Cytogenet 2012 Feb 2;5:10. Epub 2012 Feb 2.

Victorian Cancer Cytogenetics Service, St Vincent's Hospital (Melbourne), Fitzroy, Vic, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1755-8166-5-10DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3296743PMC
February 2012

A cryptic deletion in 5q31.2 provides further evidence for a minimally deleted region in myelodysplastic syndromes.

Cancer Genet 2011 Apr;204(4):187-94

Victorian Cancer Cytogenetics Service, St. Vincent's Hospital (Melbourne), Fitzroy, VIC, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cancergen.2011.02.001DOI Listing
April 2011

The paradox of 20q11.21 amplification in a subset of cases of myeloid malignancy with chromosome 20 deletion.

Genes Chromosomes Cancer 2010 Nov;49(11):998-1013

Victorian Cancer Cytogenetics Service, St Vincent's Hospital, Melbourne, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/gcc.20806DOI Listing
November 2010

Secondary clonal cytogenetic abnormalities following successful treatment of acute promyelocytic leukemia.

Am J Hematol 2009 Nov;84(11):715-9

Victorian Cancer Cytogenetics Service, St Vincent's Hospital, Melbourne, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.21528DOI Listing
November 2009

Translational control of c-MYC by rapamycin promotes terminal myeloid differentiation.

Blood 2008 Sep 11;112(6):2305-17. Epub 2008 Jul 11.

Division of Research, Peter MacCallum Cancer Centre, East Melbourne, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2007-09-111856DOI Listing
September 2008